Health Care & Life Sciences » Pharmaceuticals | Kadmon Holdings Inc.

Kadmon Holdings Inc.

Kadmon Holdings Inc.
Stock Exchange New York Stock Exchange
EPS
$0.23
Market Cap
$261.55 M
Shares Outstanding
129.48 M
Public Float
98.28 M

Profile

Address
450 East 29th Street
New York New York 10016
United States
Employees -
Website http://www.kadmon.com
Updated 07/08/2019
Kadmon Holdings, Inc. is a biopharmaceutical company, which engages in discovering, developing, and commercializing small molecules and biologics. Its products include Ribasphere RibaPak, Tetrabenazine, Valganciclovir, Abacavir, Entecavir, Lamivudine, and Zidovudine. The company was founded by Steven N.

Financials

View All
Created with Highcharts 5.0.14Kadmon Holdings Inc.Net Income. Fiscal year is January-December. All values USD Thousands.64 35664 356147 082147 082208 755208 75579 77479 77454 25254 25220142015201620172018050k100k150k200k250k
Created with Highcharts 5.0.14Kadmon Holdings Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.95 01895 01835 71935 71926 05526 05512 26412 2641 3961 39620142015201620172018025k50k75k100k

Anastasios G. Konidaris
Independent Director
Steven Meehan
Independent Director